YPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astellas Pharma Inc

Watchlist Manager

Watchlist

Price: 13.9 EUR -0.71% Market Closed

Market Cap: €24.9B

A	Astellas Pharma Inc DUS:YPH	JP
	China Resources Beer Holdings Co Ltd F:CHK	HK
S	Shaftesbury Capital PLC F:C20	UK
M	Merck & Co Inc F:6MK	US
	Clean Seed Capital Group Ltd XTSX:CSX	CA
	Shimano Inc F:SHM	JP

Profitability Summary

Astellas Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

81%

Declining Gross Margin

82% > 81%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

10% > 21%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

4% > 16%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.